Tag: entrepreneurs
-
Spin-Off Company Develops Drill-Less Tooth Cavity Treatment
16 June 2014. A spin-off company from Kings College London in the U.K. is developing a technology that makes treating tooth cavities a painless electrical process. Reminova Ltd. — located in Perth, Scotland — was founded earlier this year and is led by two Kings College dental faculty, Nigel Pitts and Chris Longbottom, who serve…
-
Stress, Diet Apps Numerous but Offer Only Short Term Help
30 May 2014. Online and mobile apps for stress management and healthy eating are numerous and gaining more users, but their impact appears to be short lived, according to an analysis by a researcher in Finland. Kirsikka Kaipainen, a research scientist at VTT Technical Research Centre in Espoo, Finland, published her findings earlier this month…
-
Epigenetics Biotech Secures $12.9 Million Early Financing
30 May 2014. Rodin Therapeutics Inc., a biotechnology company in Boston developing therapies based on epigenetics — inherited changes in genetic activity outside of DNA — raised $12.9 million in its first venture funding round. The company is a joint venture of Proteros biostructures GmbH in Munich and Atlas Ventures in Cambridge, Massachusetts. Rodin Therapeutics…
-
Students Invent Germ-Killing Catheter, Start Company
21 May 2014. Five medical and engineering students at University of Utah in Salt Lake City invented a new type of catheter that emits high-intensity light killing bacteria before they cause an infection in the patient. The students also formed a new company, Veritas Medical LLC in Salt Lake City to take the invention to…
-
Antibody Developer Secures $40M from Foundation Investors
16 May 2014. Kymab Ltd., a developer of human antibodies from mouse genomes, raised $40 million in its second round of venture investment from the Wellcome Trust, an original backer of the company, and Bill & Melinda Gates Foundation. Kymab, based in Cambridge, U.K., is also collaborating with the Gates Foundation in research on discovery…
-
Neurodegenerative Therapies Start-Up Gains $4.8M Seed Funds
12 May 2014. Lysosomal Therapeutics Inc., a start-up developer of therapies for neurodegenerative disorders in Cambridge, Massachusetts, raised $4.8 million in seed financing, the enterprise’s initial operating funds. The company was begun by and is based on the research of Dimitri Krainc, a neurologist at Harvard Medical School and Massachusetts General Hospital in Boston. Atlas…
-
New Company Formed to Commercialize Synthetic DNA Discovery
7 May 2014. Synthorx Inc., a spin-off company from Scripps Research Institute in La Jolla, California, will commercialize research licensed from Scripps that adds synthetic DNA elements into natural DNA of organisms. The research, led by Scripps chemistry professor and Synthorx co-founder Floyd Romesberg, appears today online in the journal Nature (paid subscription required). Romesberg,…
-
Immune Therapeutics Start-Up Raises $37.5M in Early Funding
6 May 2014. Anokion SA in Lausanne, Switzerland, a start-up enterprise developing therapies to treat immune systems disorders, raised 33 million Swiss francs ($US 37.5 million) in its first venture financing round. The round was led by Novartis Venture Fund, and two life-science investment companies — Novo Ventures and Versant Ventures — with participation from…
-
Cisco Venture Arm Backing Internet-of-Things Start-Ups
1 May 2014. Cisco Investments, the venture capital division of the network technologies company, is taking minority stakes in start-up companies and an accelerator that add Internet connectivity to everyday devices and products, known as Internet-of-Things. The company also plans to make $150 million in early-stage investments over the next two to three years on…
-
Cancer Immunotherapy Start-Up Completes $176M Funding Round
25 April 2014. Juno Therapeutics, a biotechnology start-up company in Seattle, completed its first round of venture financing, raising $176 million from private investors and not-for-profit research institutes. The company started in December 2013 with a stake of $120 million, but announced in January 2014 it planned to expand its financing beyond an original target…